aap Implantate AG’s initial public offering on Frankfurt Stock Exchange took place on May 10, 1999. Since October 11, 2019 aap Implantate AG’s stocks have been listed in the regulated market (General Standard) of the Frankfurt Stock Exchange.
| Company | aap Implantate AG |
| International Securities Identification Number (ISIN) | DE000A3H2101 |
| SIN (WKN) | A3H210 |
| Listing | All German Stock Exchanges, XETRA |
| Stock Symbol | AAQ1 |
| Market Segment | General Standard |
| Indices | CDAX |
| Sector | Pharma & Healthcare |
| Subsector | Medical Technology |
| Capital Stock in EUR | 10,979,625.00 |
| Capital Stock / Shares | 10,979,625 |
| Authorized Capital in EUR | 6,582,782.00 |
| Authorized Capital / Shares | 6,582,782 |
| Designated Sponsor | BankM |